Market Tracker

07/22 5:16pm ET

Alkermes Plc (NASDAQ:ALKS)

49.80
Delayed Data
As of Jul 22
 +0.83 / +1.69%
Today’s Change
27.14
Today|||52-Week Range
80.71
-37.26%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close48.97
Today’s open49.02
Day’s range48.56 - 49.89
Volume467,779
Average volume (3 months)1,188,256
Market cap$7.5B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+19.54%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.71

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-1.66-6.78%
MNKMallinckrodt Plc-1.04-1.54%
IDXXIDEXX Laboratories I...+0.18+0.19%
JAZZJazz Pharmaceuticals...-1.58-1.10%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts